KTTA – pasithea therapeutics corp. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

KTTA

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

4/1

07:16 am

ktta

Pasithea Therapeutics Announces Grant of Fast Track Designation by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) Causing Significant Morbidity [TheStreet.com]

Low Report

Report

4/1

07:01 am

ktta

Pasithea Therapeutics Announces Grant of Fast Track Designation by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) Causing Significant Morbidity

High Report

Pasithea Therapeutics Announces Grant of Fast Track Designation by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) Causing Significant Morbidity

Report

2/27

05:26 am

ktta

Pasithea Therapeutics Corp. (KTTA) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference Transcript [Seeking Alpha]

Medium Report

Pasithea Therapeutics Corp. (KTTA) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference Transcript [Seeking Alpha]

Report

2/17

07:30 am

ktta

Pasithea Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference [Yahoo! Finance]

Low Report

Pasithea Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference [Yahoo! Finance]

Report

2/17

07:01 am

ktta

Pasithea Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

Low Report

Pasithea Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

Report

1/18

01:00 am

ktta

Pasithea Therapeutics (NASDAQ:KTTA) was upgraded by analysts at Wall Str

Low Report

Pasithea Therapeutics (NASDAQ:KTTA) was upgraded by analysts at Wall Str

Report

1/13

07:01 am

ktta

Pasithea Therapeutics Provides Outlook on PAS-004 Clinical Programs and Data Release Timelines

Low Report

Pasithea Therapeutics Provides Outlook on PAS-004 Clinical Programs and Data Release Timelines

Report

1/10

01:07 am

ktta

Pasithea Therapeutics (NASDAQ:KTTA) was upgraded by analysts at Wall Str

Low Report

Pasithea Therapeutics (NASDAQ:KTTA) was upgraded by analysts at Wall Str

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.